| Reference |
|---|
Uehara N, Shibusawa N, Mikami Y, Kyumoto Nakamura Y, Sonoda S, Kato H, et al. Bone metastatic mammary tumor cell-derived extracellular vesicles inhibit osteoblast maturation via JNK signaling. Arch Biochem Biophys. 2023;750:109821 pubmed publisher |
Cho E, Che X, Ang M, Cheon S, Lee J, Kim K, et al. Peroxiredoxin 5 regulates osteogenic differentiation through interaction with hnRNPK during bone regeneration. elife. 2023;12: pubmed publisher |
Polan C, Brenner C, Herten M, Hilken G, Grabellus F, Meyer H, et al. Increased UHMWPE Particle-Induced Osteolysis in Fetuin-A-Deficient Mice. J Funct Biomater. 2023;14: pubmed publisher |
Yong J, Gr xf6 ger S, von Bremen J, Ruf S. Ciliary Neurotrophic Factor (CNTF) Inhibits In Vitro Cementoblast Mineralization and Induces Autophagy, in Part by STAT3/ERK Commitment. Int J Mol Sci. 2022;23: pubmed publisher |
Wu J, Sun Z, Liu S, Chen Z, Yuan Z, Zou M, et al. The ASIC3-M-CSF-M2 macrophage-positive feedback loop modulates fibroblast-to-myofibroblast differentiation in skin fibrosis pathogenesis. Cell Death Dis. 2022;13:527 pubmed publisher |
Smeda M, Galler K, Woelflick M, Rosendahl A, Moehle C, Lenhardt B, et al. Molecular Biological Comparison of Dental Pulp- and Apical Papilla-Derived Stem Cells. Int J Mol Sci. 2022;23: pubmed publisher |
Junqueira J, Louren xe7 o J, da Silva K, Jorgetti V, Vieira R, de Araujo A, et al. Increased bone resorption by long-term cigarette smoke exposure in animal model. Heliyon. 2021;7:e08587 pubmed publisher |
Zhao W, Wiedemann P, Wölfel E, Neven M, Peters S, Imhof T, et al. Decreased Trabecular Bone Mass in Col22a1-Deficient Mice. Cells. 2021;10: pubmed publisher |
Liao N, Koehne T, Tuckermann J, Triviai I, Amling M, David J, et al. Osteoblast-specific inactivation of p53 results in locally increased bone formation. PLoS ONE. 2021;16:e0249894 pubmed publisher |
Lee E, Na W, Kang M, Kim Y, Kim D, Oh H, et al. Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes. Biomedicines. 2021;9: pubmed publisher |
Li W, Wei C, Xu L, Yu B, Chen Y, Lu D, et al. Schistosome infection promotes osteoclast-mediated bone loss. PLoS Pathog. 2021;17:e1009462 pubmed publisher |
Timmen M, Hidding H, G xf6 tte M, Khassawna T, Kronenberg D, Stange R. The heparan sulfate proteoglycan Syndecan-1 influences local bone cell communication via the RANKL/OPG axis. Sci Rep. 2020;10:20510 pubmed publisher |
Hannappe M, Arnould L, Meloux A, Mouhat B, Bichat F, Zeller M, et al. Vascular density with optical coherence tomography angiography and systemic biomarkers in low and high cardiovascular risk patients. Sci Rep. 2020;10:16718 pubmed publisher |
Cawley K, Bustamante Gomez N, Guha A, MacLeod R, Xiong J, Gubrij I, et al. Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption. Cell Rep. 2020;32:108052 pubmed publisher |
Tsukasaki M, Asano T, Muro R, Huynh N, Komatsu N, Okamoto K, et al. OPG Production Matters Where It Happened. Cell Rep. 2020;32:108124 pubmed publisher |
Velletri T, Huang Y, Wang Y, Li Q, Hu M, Xie N, et al. Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin. Cell Death Differ. 2021;28:156-169 pubmed publisher |
Sahbani K, Cardozo C, Bauman W, TAWFEEK H. Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide. Physiol Rep. 2019;7:e14225 pubmed publisher |
Heckt T, Brylka L, Neven M, Amling M, Schinke T. Deficiency of sphingosine-1-phosphate receptor 3 does not affect the skeletal phenotype of mice lacking sphingosine-1-phosphate lyase. PLoS ONE. 2019;14:e0219734 pubmed publisher |
Kang J, Choi Y, Seo B, Jo U, Park S, Kim Y, et al. A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment. Sci Rep. 2019;9:8726 pubmed publisher |
Pesaro A, Katz M, Liberman M, Pereira C, Mangueira C, de Carvalho A, et al. Circulating osteogenic proteins are associated with coronary artery calcification and increase after myocardial infarction. PLoS ONE. 2018;13:e0202738 pubmed publisher |
Zimmerman S, Heard Lipsmeyer M, Dimori M, Thostenson J, Mannen E, O Brien C, et al. Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim). Bone Rep. 2018;9:61-73 pubmed publisher |
Xiong J, Cawley K, Piemontese M, Fujiwara Y, Zhao H, Goellner J, et al. Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss. Nat Commun. 2018;9:2909 pubmed publisher |
Lee N, Clarke I, Enriquez R, Nagy V, Penninger J, Baldock P, et al. Central RANK signalling in NPY neurons alters bone mass in male mice. Neuropeptides. 2018;68:75-83 pubmed publisher |
Yang N, Baban B, Isales C, Shi X. Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss. PLoS ONE. 2017;12:e0181133 pubmed publisher |
Hulley P, Bishop T, Vernet A, Schneider J, Edwards J, Athanasou N, et al. Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2. J Pathol. 2017;242:322-333 pubmed publisher |
Park O, Kim J, Yang J, Yun C, Han S. Muramyl Dipeptide, a Shared Structural Motif of Peptidoglycans, Is a Novel Inducer of Bone Formation through Induction of Runx2. J Bone Miner Res. 2017;32:1455-1468 pubmed publisher |
Davis H, Pacheco Costa R, Atkinson E, Brun L, Gortazar A, Harris J, et al. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging. Aging Cell. 2017;16:551-563 pubmed publisher |
Pezzotti G, McEntire B, Bock R, Boffelli M, Zhu W, Vitale E, et al. Silicon Nitride: A Synthetic Mineral for Vertebrate Biology. Sci Rep. 2016;6:31717 pubmed publisher |
Iyer S, Han L, Ambrogini E, Yavropoulou M, Fowlkes J, Manolagas S, et al. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes. J Bone Miner Res. 2017;32:60-69 pubmed publisher |
Kassem A, Henning P, Lundberg P, Souza P, Lindholm C, Lerner U. Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts. J Biol Chem. 2015;290:20147-58 pubmed publisher |
Maruyama K, Fukasaka M, Uematsu S, Takeuchi O, Kondo T, Saitoh T, et al. 5-Azacytidine-induced protein 2 (AZI2) regulates bone mass by fine-tuning osteoclast survival. J Biol Chem. 2015;290:9377-86 pubmed publisher |
Baek J, Kim J, Cheon Y, Park S, Ahn S, Yoon K, et al. Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone. Molecules. 2014;19:11628-44 pubmed publisher |
Teufel S, Grötsch B, Luther J, Derer A, Schinke T, Amling M, et al. Inhibition of bone remodeling in young mice by bisphosphonate displaces the plasma cell niche into the spleen. J Immunol. 2014;193:223-33 pubmed publisher |
Yoo Y, Kwag J, Kim K, Kim C. Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. Int J Mol Sci. 2014;15:5874-83 pubmed publisher |
Hayashida C, Ito J, Nakayachi M, Okayasu M, Ohyama Y, Hakeda Y, et al. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. J Biol Chem. 2014;289:11545-55 pubmed publisher |
Ohba T, Cole H, Cates J, Slosky D, Haro H, Ando T, et al. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. J Bone Miner Res. 2014;29:1431-45 pubmed publisher |
Wintges K, Beil F, Albers J, Jeschke A, Schweizer M, Claass B, et al. Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C-C motif) ligand 5 (Ccl5). J Bone Miner Res. 2013;28:2070-80 pubmed publisher |
Gao L, Faibish D, Fredman G, Herrera B, Chiang N, Serhan C, et al. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol. 2013;190:689-94 pubmed publisher |
Buckle C, De Leenheer E, Lawson M, Yong K, Rabin N, Perry M, et al. Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. PLoS ONE. 2012;7:e41127 pubmed publisher |
Hayashi M, Nakashima T, Taniguchi M, Kodama T, Kumanogoh A, Takayanagi H. Osteoprotection by semaphorin 3A. Nature. 2012;485:69-74 pubmed publisher |
Ma B, Zhang Q, Wu D, Wang Y, Hu Y, Cheng Y, et al. Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. Acta Pharmacol Sin. 2012;33:479-89 pubmed publisher |
Onal M, Galli C, Fu Q, Xiong J, Weinstein R, Manolagas S, et al. The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice. Mol Endocrinol. 2012;26:341-8 pubmed publisher |
Ho T, Santora K, Chen J, Frankshun A, Bagnell C. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. Bone. 2011;48:1346-53 pubmed publisher |
Sample S, Collins R, Wilson A, Racette M, Behan M, Markel M, et al. Systemic effects of ulna loading in male rats during functional adaptation. J Bone Miner Res. 2010;25:2016-28 pubmed publisher |
Neunaber C, Catala Lehnen P, Beil F, Marshall R, Kanbach V, Baranowsky A, et al. Increased trabecular bone formation in mice lacking the growth factor midkine. J Bone Miner Res. 2010;25:1724-35 pubmed publisher |
Sauer A, Mrak E, Hernandez R, Zacchi E, Cavani F, Casiraghi M, et al. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. Blood. 2009;114:3216-26 pubmed publisher |
O Connor R, Zayzafoon M, Farach Carson M, Schanen N. Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone. 2009;45:346-56 pubmed publisher |
Pierroz D, Rufo A, Bianchi E, Glatt V, Capulli M, Rucci N, et al. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. J Bone Miner Res. 2009;24:775-84 pubmed publisher |
Qiang Y, Chen Y, Stephens O, Brown N, Chen B, Epstein J, et al. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. Blood. 2008;112:196-207 pubmed publisher |
Morony S, Tintut Y, Zhang Z, Cattley R, Van G, Dwyer D, et al. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation. 2008;117:411-20 pubmed publisher |
Secchiero P, Corallini F, Rimondi E, Chiaruttini C, di Iasio M, Rustighi A, et al. Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells. Blood. 2008;111:1287-94 pubmed |
Zhu J, Jia X, Xiao G, Kang Y, Partridge N, Qin L. EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts: implications for osteolytic bone metastases. J Biol Chem. 2007;282:26656-64 pubmed |
Li Y, Toraldo G, Li A, Yang X, Zhang H, Qian W, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood. 2007;109:3839-48 pubmed |
Nakamichi Y, Udagawa N, Kobayashi Y, Nakamura M, Yamamoto Y, Yamashita T, et al. Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand derived from osteoblasts. J Immunol. 2007;178:192-200 pubmed |
Berry J, Ealba E, Pettway G, Datta N, Swanson E, Somerman M, et al. JunB as a downstream mediator of PTHrP actions in cementoblasts. J Bone Miner Res. 2006;21:246-57 pubmed |
Zehnder A, Kristiansen A, Adams J, Merchant S, McKenna M. Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule. Laryngoscope. 2005;115:172-7 pubmed |
Lubberts E, van den Bersselaar L, Oppers Walgreen B, Schwarzenberger P, Coenen de Roo C, Kolls J, et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol. 2003;170:2655-62 pubmed |
